Assenagon Asset Management’s Clearside Biomedical CLSD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Hold |
131,913
| – | – | ﹤0.01% | 1112 |
|
|
2025
Q1 | $121K | Hold |
131,913
| – | – | ﹤0.01% | 1107 |
|
|
2024
Q4 | $125K | Sell |
131,913
-125,190
| -49% | -$119K | ﹤0.01% | 1268 |
|
|
2024
Q3 | $327K | Sell |
257,103
-26,090
| -9% | -$33.1K | ﹤0.01% | 1248 |
|
|
2024
Q2 | $368K | Buy |
+283,193
| New | +$368K | ﹤0.01% | 1248 |
|
|
2023
Q4 | – | Sell |
-71,776
| Closed | -$62.4K | – | 1366 |
|
|
2023
Q3 | $62.4K | Hold |
71,776
| – | – | ﹤0.01% | 1320 |
|
|
2023
Q2 | $80.4K | Sell |
71,776
-79,862
| -53% | -$89.4K | ﹤0.01% | 1258 |
|
|
2023
Q1 | $158K | Sell |
151,638
-15,944
| -10% | -$16.6K | ﹤0.01% | 1330 |
|
|
2022
Q4 | $188K | Sell |
167,582
-243,109
| -59% | -$273K | ﹤0.01% | 1264 |
|
|
2022
Q3 | $464K | Sell |
410,691
-345,509
| -46% | -$390K | ﹤0.01% | 1065 |
|
|
2022
Q2 | $1.11M | Sell |
756,200
-157,589
| -17% | -$232K | ﹤0.01% | 1021 |
|
|
2022
Q1 | $2.09M | Sell |
913,789
-720,623
| -44% | -$1.65M | 0.01% | 797 |
|
|
2021
Q4 | $4.5M | Buy |
1,634,412
+1,615,538
| +8,560% | +$4.44M | 0.01% | 520 |
|
|
2021
Q3 | $113K | Buy |
+18,874
| New | +$113K | ﹤0.01% | 1216 |
|
|
2021
Q2 | – | Sell |
-121,317
| Closed | -$300K | – | 1191 |
|
|
2021
Q1 | $300K | Buy |
+121,317
| New | +$300K | ﹤0.01% | 1062 |
|